ANNX · Annexon Inc. Common Stock
View on chartInsiders & Stakes
| Muneer A. Satter Director | ▲ Buy | Open Market | 10,342,134 Shares held | 5/28/2026 | View profile |
| Bain Capital Life Sciences Investors, LLC 10% Owner | ▲ Buy | Open Market | 5,701,926 Shares held | 5/25/2023 | View profile |
| Love Douglas PRESIDENT AND CEO | ▲ Buy | Open Market | 390,476 Shares held | 9/24/2026 | View profile |
| Ted Yednock EVP & Chief Scientific Officer | ▲ Buy | Option Exercise | 184,807 Shares held | 6/11/2026 | View profile |
| Michael Overdorf EVP & Chief Business Officer | ▼ Sell | Open Market | 182,625 Shares held | 3/2/2026 | View profile |
| Dean Richard Artis EVP & CHIEF SCIENTIFIC OFFICER | ▼ Sell | Open Market | 180,093 Shares held | 3/2/2026 | View profile |
| Jennifer Lew EVP & Chief Financial Officer | ▼ Sell | Open Market | 170,700 Shares held | 3/2/2026 | View profile |
| Jamie Dananberg CHIEF MEDICAL OFFICER | ▼ Sell | Open Market | 123,582 Shares held | 3/2/2026 | View profile |
| William H. Carson | ▲ Buy | Open Market | 78,405 Shares held | 5/11/2026 | View profile |
| Jung Choi | ▲ Buy | Open Market | 33,000 Shares held | 12/1/2025 | View profile |
| Mattheakis Larry EVP & Chief Scientific Officer | ▲ Buy | Grant | 17,188 Shares held | 7/11/2022 | View profile |
| Sanjay Chandru Keswani Chief Medical Officer | ▲ Buy | Grant | 12,500 Shares held | 2/11/2022 | View profile |
Transaction History
| Love Douglas | ▲ Buy | Open Market | 26,065 | $100K | 9/24/2026 |
| Ted Yednock | ▲ Buy | Option Exercise | 30,646 | $57K | 6/11/2026 |
| Muneer A. Satter | ▲ Buy | Open Market | 613,497 | $3.3M | 5/28/2026 |
| William H. Carson | ▲ Buy | Open Market | 8,000 | $46K | 5/11/2026 |
| William H. Carson | ▲ Buy | Open Market | 8,000 | $50K | 4/10/2026 |
| William H. Carson | ▲ Buy | Open Market | 8,000 | $45K | 3/10/2026 |
| Jamie Dananberg | ▼ Sell | Open Market | 5,820 | $32K | 3/2/2026 |
| Michael Overdorf | ▼ Sell | Open Market | 4,339 | $24K | 3/2/2026 |
| Ted Yednock | ▼ Sell | Open Market | 5,566 | $30K | 3/2/2026 |
| Dean Richard Artis | ▼ Sell | Open Market | 5,894 | $32K | 3/2/2026 |
| Jennifer Lew | ▼ Sell | Open Market | 5,565 | $30K | 3/2/2026 |
| Jamie Dananberg | ▲ Buy | Grant | 56,250 | $0 | 2/19/2026 |
| Michael Overdorf | ▲ Buy | Grant | 62,500 | $0 | 2/19/2026 |
| Dean Richard Artis | ▲ Buy | Grant | 62,500 | $0 | 2/19/2026 |
| Ted Yednock | ▲ Buy | Grant | 62,500 | $0 | 2/19/2026 |
| Jennifer Lew | ▲ Buy | Grant | 62,500 | $0 | 2/19/2026 |
| Jamie Dananberg | ▼ Sell | Open Market | 5,290 | $27K | 2/18/2026 |
| Jennifer Lew | ▼ Sell | Open Market | 7,851 | $40K | 2/18/2026 |
| Dean Richard Artis | ▼ Sell | Open Market | 5,290 | $27K | 2/18/2026 |
| Ted Yednock | ▼ Sell | Open Market | 7,857 | $40K | 2/18/2026 |
| Michael Overdorf | ▼ Sell | Open Market | 6,225 | $32K | 2/18/2026 |
| William H. Carson | ▲ Buy | Open Market | 4,115 | $21K | 12/30/2025 |
| Jung Choi | ▲ Buy | Open Market | 33,000 | $138K | 12/1/2025 |
| William H. Carson | ▲ Buy | Open Market | 4,115 | $18K | 12/1/2025 |
| Muneer A. Satter | ▲ Buy | Open Market | 422,613 | $1.8M | 11/21/2025 |
| Muneer A. Satter | ▲ Buy | Open Market | 400,000 | $1.8M | 11/20/2025 |
| Muneer A. Satter | ▲ Buy | Open Market | 500,000 | $2.0M | 11/19/2025 |
| Muneer A. Satter | ▲ Buy | Open Market | 500,000 | $1.6M | 11/18/2025 |
| Muneer A. Satter | ▲ Buy | Open Market | 500,000 | $1.5M | 11/17/2025 |
| William H. Carson | ▲ Buy | Open Market | 4,115 | $13K | 10/30/2025 |
| William H. Carson | ▲ Buy | Open Market | 4,115 | $13K | 9/30/2025 |
| William H. Carson | ▲ Buy | Open Market | 4,115 | $9K | 9/2/2025 |
| William H. Carson | ▲ Buy | Open Market | 4,115 | $10K | 7/30/2025 |
| Ted Yednock | ▼ Sell | Open Market | 1,116 | $3K | 7/14/2025 |
| Jennifer Lew | ▼ Sell | Open Market | 1,117 | $3K | 7/14/2025 |
| Michael Overdorf | ▼ Sell | Open Market | 853 | $2K | 7/14/2025 |
| William H. Carson | ▲ Buy | Open Market | 4,115 | $10K | 6/30/2025 |
| Jamie Dananberg | ▼ Sell | Open Market | 5,521 | $16K | 2/18/2025 |
| Dean Richard Artis | ▼ Sell | Open Market | 5,515 | $16K | 2/18/2025 |
| Ted Yednock | ▼ Sell | Open Market | 8,345 | $24K | 2/18/2025 |
| Michael Overdorf | ▼ Sell | Open Market | 6,618 | $20K | 2/18/2025 |
| Jennifer Lew | ▼ Sell | Open Market | 6,912 | $20K | 2/18/2025 |
| Love Douglas | ▼ Sell | Open Market | 5,021 | $15K | 2/13/2025 |
| Jennifer Lew | ▼ Sell | Open Market | 1,786 | $5K | 2/13/2025 |
| Michael Overdorf | ▼ Sell | Open Market | 1,425 | $4K | 2/13/2025 |
| Ted Yednock | ▼ Sell | Open Market | 1,783 | $5K | 2/13/2025 |
| Love Douglas | ▲ Buy | Option Exercise | 37,994 | $54K | 1/6/2025 |
| William H. Carson | ▲ Buy | Open Market | 3,200 | $17K | 12/2/2024 |
| Love Douglas | ▲ Buy | Option Exercise | 78,399 | $145K | 10/30/2024 |
| Love Douglas | ▲ Buy | Option Exercise | 36,050 | $67K | 10/30/2024 |
| Ted Yednock | ▲ Buy | Option Exercise | 5,408 | $10K | 10/15/2024 |
| Ted Yednock | ▼ Sell | Open Market | 5,408 | $40K | 10/15/2024 |
| William H. Carson | ▲ Buy | Open Market | 3,200 | $19K | 10/1/2024 |
| Ted Yednock | ▼ Sell | Open Market | 4,500 | $32K | 9/19/2024 |
| Ted Yednock | ▼ Sell | Open Market | 5,500 | $34K | 9/12/2024 |
| Ted Yednock | ▼ Sell | Open Market | 5,500 | $31K | 9/5/2024 |
| William H. Carson | ▲ Buy | Open Market | 3,200 | $18K | 9/3/2024 |
| Ted Yednock | ▼ Sell | Open Market | 5,500 | $33K | 8/29/2024 |
| William H. Carson | ▲ Buy | Open Market | 3,200 | $20K | 8/1/2024 |
| Michael Overdorf | ▼ Sell | Open Market | 784 | $5K | 7/15/2024 |
| Jennifer Lew | ▼ Sell | Open Market | 1,104 | $7K | 7/15/2024 |
| Ted Yednock | ▼ Sell | Open Market | 1,106 | $7K | 7/15/2024 |
| William H. Carson | ▲ Buy | Open Market | 3,200 | $16K | 7/1/2024 |
| William H. Carson | ▲ Buy | Open Market | 3,200 | $15K | 6/3/2024 |
| William H. Carson | ▲ Buy | Open Market | 3,200 | $15K | 5/1/2024 |
| William H. Carson | ▲ Buy | Open Market | 3,200 | $19K | 4/8/2024 |
| Michael Overdorf | ▲ Buy | Grant | 44,963 | $0 | 2/27/2024 |
| Dean Richard Artis | ▲ Buy | Grant | 44,963 | $0 | 2/27/2024 |
| Jamie Dananberg | ▲ Buy | Grant | 44,963 | $0 | 2/27/2024 |
| Jennifer Lew | ▲ Buy | Grant | 44,963 | $0 | 2/27/2024 |
| Ted Yednock | ▲ Buy | Grant | 44,963 | $0 | 2/27/2024 |
| Jennifer Lew | ▼ Sell | Open Market | 2,593 | $14K | 2/20/2024 |
| Ted Yednock | ▼ Sell | Open Market | 2,604 | $14K | 2/20/2024 |
| Michael Overdorf | ▼ Sell | Open Market | 1,951 | $11K | 2/20/2024 |
| Jennifer Lew | ▲ Buy | Grant | 39,000 | $0 | 2/16/2024 |
| Michael Overdorf | ▲ Buy | Grant | 39,000 | $0 | 2/16/2024 |
| Jamie Dananberg | ▲ Buy | Grant | 39,000 | $0 | 2/16/2024 |
| Dean Richard Artis | ▲ Buy | Grant | 39,000 | $0 | 2/16/2024 |
| Ted Yednock | ▲ Buy | Grant | 39,000 | $0 | 2/16/2024 |
| Michael Overdorf | ▼ Sell | Open Market | 1,349 | $7K | 2/12/2024 |
| Love Douglas | ▼ Sell | Open Market | 5,782 | $32K | 2/12/2024 |
| Jennifer Lew | ▼ Sell | Open Market | 1,809 | $10K | 2/12/2024 |
| Ted Yednock | ▼ Sell | Open Market | 1,810 | $10K | 2/12/2024 |
| Ted Yednock | ▲ Buy | Option Exercise | 10,385 | $19K | 12/27/2023 |
| Ted Yednock | ▲ Buy | Option Exercise | 10,615 | $15K | 12/27/2023 |
| Ted Yednock | ▼ Sell | Open Market | 21,000 | $95K | 12/27/2023 |
| Muneer A. Satter | ▲ Buy | Open Market | 350,000 | $1.0M | 12/26/2023 |
| Michael Overdorf | ▼ Sell | Open Market | 978 | $4K | 7/11/2023 |
| Jennifer Lew | ▼ Sell | Open Market | 1,057 | $4K | 7/11/2023 |
| Bain Capital Life Sciences Investors, LLC | ▲ Buy | Open Market | 300,000 | $640K | 5/25/2023 |
| Jennifer Lew | ▲ Buy | Grant | 18,975 | $0 | 2/16/2023 |
| Michael Overdorf | ▲ Buy | Grant | 18,975 | $0 | 2/16/2023 |
| Love Douglas | ▼ Sell | Open Market | 6,571 | $39K | 2/15/2023 |
| Michael Overdorf | ▼ Sell | Open Market | 144 | $907 | 2/14/2023 |
| Jennifer Lew | ▼ Sell | Open Market | 166 | $1K | 2/14/2023 |
| Michael Overdorf | ▼ Sell | Open Market | 1,501 | $9K | 2/13/2023 |
| Jennifer Lew | ▼ Sell | Open Market | 1,742 | $11K | 2/13/2023 |
| Muneer A. Satter | ▲ Buy | Open Market | 2,647,058 | $18.0M | 2/10/2023 |
| Michael Overdorf | ▲ Buy | Grant | 9,375 | $0 | 7/11/2022 |
| Mattheakis Larry | ▲ Buy | Grant | 4,688 | $0 | 7/11/2022 |
| Mattheakis Larry | ▲ Buy | Grant | 4,688 | $0 | 7/11/2022 |
| Jennifer Lew | ▲ Buy | Grant | 9,375 | $0 | 7/11/2022 |
| Muneer A. Satter | ▲ Buy | Open Market | 2,453,988 | $9.4M | 7/7/2022 |
| Love Douglas | ▲ Buy | Open Market | 60,000 | $147K | 4/14/2022 |
| Jennifer Lew | ▲ Buy | Grant | 12,500 | $0 | 2/11/2022 |
| Love Douglas | ▲ Buy | Grant | 40,000 | $0 | 2/11/2022 |
| Michael Overdorf | ▲ Buy | Grant | 12,500 | $0 | 2/11/2022 |
| Sanjay Chandru Keswani | ▲ Buy | Grant | 12,500 | $0 | 2/11/2022 |
| Mattheakis Larry | ▲ Buy | Grant | 12,500 | $0 | 2/11/2022 |
| Love Douglas | ▲ Buy | Option Exercise | 70,942 | $100K | 11/11/2021 |
| Love Douglas | ▲ Buy | Option Exercise | 30,000 | $56K | 11/11/2021 |
| Love Douglas | ▲ Buy | Option Exercise | 7,500 | $11K | 9/16/2021 |
| Love Douglas | ▼ Sell | Open Market | 7,500 | $165K | 9/16/2021 |
| Ted Yednock | ▲ Buy | Option Exercise | 15,000 | $21K | 9/13/2021 |
| Ted Yednock | ▲ Buy | Option Exercise | 1,190 | $6K | 9/13/2021 |
| Ted Yednock | ▼ Sell | Open Market | 16,190 | $324K | 9/13/2021 |
| Jennifer Lew | ▲ Buy | Option Exercise | 3,500 | $26K | 9/13/2021 |
| Jennifer Lew | ▼ Sell | Open Market | 3,500 | $70K | 9/13/2021 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
ANNX Listed Among Health Care Stocks Moving Pre-Market
Annexon Inc. was included in a list of health care stocks showing movement during Friday's pre-market session. The stock is currently trading near its 52-week low, with technical signals indicating a breakdown below the Bollinger Bands. Analysts maintain a wide range of price targets, reflecting uncertainty about the company's future performance.
ANNX Listed Among Health Care Stocks Moving Pre-Market. Annexon Inc. was included in a list of health care stocks showing movement during Friday's pre-market session. The stock is currently trading near its 52-week low, with technical signals indicating a breakdown below the Bollinger Bands. Analysts maintain a wide range of price targets, reflecting uncertainty about the company's future performance.